This comprehensive book captures and compiles new and current information on hematologic malignancies. New knowledge of cellular disease processes molecular pathology and cytogenetic epigenetic and genomic changes has influenced the current outlook toward haematological malignancies. This recent and ongoing expansion of knowledge on malignant hematology has not previously been utilized to its full capacity due to its diffuse distribution scattered over the internet and research publications. This book is written by experts from the American and European continent sharing their current thoughts and knowledge on the pathobiology of malignant haematological diseases of the blood as well as current treatment strategies and future developments in the area of these haematological diseases.